or Try an Advanced Search...

    ETF Components for BBP - BioShares Biotechnology Products Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TARS B -0.40 3.80
    ADMA A 0.00 3.17
    LXRX F 0.92 2.71
    SWTX D -5.70 2.60
    AGIO B 0.00 2.58
    SRPT D -0.95 2.58
    ITCI A 0.74 2.54
    MRNA A -1.20 2.51
    LGND B 0.50 2.46
    ASND C -1.17 2.45
    NBIX C -1.04 2.28
    BPMC A -3.19 2.14
    KNSA D -0.18 2.13
    REGN C 0.02 2.12
    APLS F -0.19 2.07
    EXEL A -0.56 2.04
    VRTX C -0.02 2.02
    HALO D 1.32 2.02
    AMGN D 1.58 2.00
    DCPH D 0.84 1.95
    AXSM F 2.77 1.95
    BMRN A -1.26 1.94
    CRSP F -2.18 1.92
    RARE D -3.14 1.92
    PTCT F 0.73 1.91
    UTHR A 0.13 1.90
    INSM D -3.95 1.88
    RYTM D -0.71 1.87
    TBPH B -0.65 1.83
    HRMY D 1.52 1.83
    FOLD D 2.47 1.76
    IMCR D 0.64 1.74
    BNTX F 0.51 1.73
    INCY F -1.00 1.73
    IONS D -0.22 1.73
    GILD F 0.27 1.71
    LEGN F -2.12 1.70
    ALNY F -0.78 1.64
    BIIB F 0.89 1.58
    SAGE F 0.58 1.53
    BGNE F -1.36 1.49
    BCRX F -4.33 1.49
    TVTX F -2.59 1.48
    BBIO F -1.80 1.46
    MIRM F 0.17 1.44
    IRWD F 2.57 1.43
    ACAD F -1.41 1.27
    AUPH F 2.29 1.15
    ZLAB F -0.56 0.99
    BLUE F 3.16 0.62

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Infectious Diseases Nasdaq 100 Rare Diseases S&P 500 Biology Chemical Compounds Organ Systems Pain Alzheimer's Disease Diabetes Disease Dystrophy Monoclonal Antibodies Spinal Muscular Atrophy
    Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

    Recent News for BioShares Biotechnology Products Fund & its Holdings

    Date Stock Title
    Apr 19 FOLD When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
    Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
    Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
    Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
    Apr 19 TARS Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
    Apr 19 CRSP ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential
    Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
    Apr 19 VRTX Is Vertex Pharmaceuticals Stock a Millionaire Maker?
    Apr 19 MRNA FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
    Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
    Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
    Apr 18 REGN Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
    Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
    Apr 18 HALO Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
    Apr 18 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
    Apr 18 ADMA Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
    Apr 18 SAGE Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
    Apr 18 AUPH Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024
    Apr 18 MIRM Stifel starts Mirum at buy, cites IBATi drug potential
    Apr 18 SAGE Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    The BioShares Biotechnology Products Fund (BBP) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
    Exchange Traded Fund ETF Biotechnology Technology Products Biotechnology Products
    Back to the Main BBP Page...